Lenvatinib: A Key Malignant growth Helpful Lenvatinib, advertised under the brand name Lenvima, is an oral tyrosine kinase inhibitor endorsed for the therapy of separated thyroid malignant growth, renal cell carcinoma, hepatocellular carcinoma, and, all the more as of late, endometrial disease. https://businessguruzz.com/2024/10/30/lenvatinib-and-generic-truvada-cost/